default-logo
Teléfono : +34 932 021 335
info@oncothermiabarcelona.com

Clinical Case: Oncothermia in the treatment of stage IV Kidney Cancer (Wilms tumor)

25 February, 2019

Cáncer de riñónWilms tumor is the most frequent cause of kidney cancer in childhood and adolescence.

It also carries a death rate of 7–8 in a million. The 5-year event-free survival and overall survival reach 77.2 and 87.5%. There are no other proper remedies apart from radiotherapy and chemotherapy as ways to cure Wilms tumor in case of tumor progress.

Dr. Lee’s team recently published in the journal Case Reports in Oncology (Case Rep Oncol 2016 Jan-Apr; 9 (1): 119-125), an integrative medical treatment consisting of: oncothermia, thymosin-α1 and phytotherapy . The treatment contributed to the remission of hepatic metastases, stage IV Wilms tumor. Also a stable maintenance of metastasis in the lung.

Clinical case

A 17-year-old Korean woman was treated from October 25, 2014, until July 22, 2015 with an integrating medical treatment, in order to control the extent of her illness. The integrative medical treatment included: oncothermia, thymosin-α1 and phytotherapy. Phytotherapy was administered in 8 ml. of inhalation of Soram nebulizer solution qd, Soramdan S 8 g po, Hangamdan S 1 g po, tid, Cheongjangtang 10-30 ml, and Spiam HC 8 g po. She received Oncothermia (2-3 times a week) and 1.6 mg of treatment with thymosin-α1 (Zadaxin) i.m. According to the result of the CT on July 15, 2015, the liver metastasis was no longer seen, while the lung metastasis remained stable without tumor progression.

Conclusion

In patterns of Wilms tumor progression after surgery and chemotherapy, integrative medical treatment can be significant for disease control.